James B. Renacci sold ACCELERON PHARMA INCORPORATED (XLRN) (XLRN)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 5 trades in ACCELERON PHARMA INCORPORATED (XLRN) (XLRN) since 2014, 4 purchases and 1 sale, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of ACCELERON PHARMA INCORPORATED (XLRN) (XLRN) on February 10, 2017. Since that trade, XLRN is up +0.00% against the S&P 500 up +264.95%, an outperformance of -264.95%.
Across these filings, James B. Renacci has been a net buyer of XLRN (a buy-to-sell ratio of 4.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's XLRN trades vs the price
XLRN is up +0.00% since James B. Renacci sold on February 10, 2017, versus +264.95% for the S&P 500.
Performance since this trade
All James B. Renacci XLRN trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & XLRN trading FAQ
Is it legal for James B. Renacci to trade ACCELERON PHARMA INCORPORATED (XLRN) (XLRN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including ACCELERON PHARMA INCORPORATED (XLRN) (XLRN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell XLRN?
James B. Renacci disclosed a sale of $15,001 - $50,000 of ACCELERON PHARMA INCORPORATED (XLRN) (XLRN) on February 10, 2017, according to public STOCK Act filings.
How has XLRN performed since James B. Renacci's trade?
Since James B. Renacci sold XLRN on February 10, 2017, the stock is up +0.00%, versus +264.95% for the S&P 500 over the same period, an outperformance of -264.95%.
How many times has James B. Renacci traded XLRN?
James B. Renacci has disclosed 5 XLRN trades since 2014 (4 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional XLRN trades?
Quantellect tracks every disclosed congressional trade in ACCELERON PHARMA INCORPORATED (XLRN) (XLRN) on the ACCELERON PHARMA INCORPORATED (XLRN) congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's XLRN tradesAll congressional filings for ACCELERON PHARMA INCORPORATED (XLRN)James B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.